Merck vet Robert Plenge moves to Celgene, Gritstone recruits a Genentech star and more
→ ImCheck not only has a recent €20 million Series A under its belt, the biotech also named Pierre d’Epenoux as it Chief Executive …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
